United Kingdom Biotechnology & Medical Research

Hemogenyx Pharmaceuticals PLC (HEMO)

Track

Track

Hemogenyx Pharmaceuticals PLC has recorded no insider trading activity within the last three months. The most recent transaction occurred on May 27, 2022, when Financial Controller Andrew Wright purchased shares. Historical data shows consistent buying patterns from company leadership over several years, though these events predate the current quarter.
Ticker: HEMO Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Hemogenyx Pharmaceuticals PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Andrew Wright Financial Controller and Company Secretary
Transaction date
Purchase
Price
152.05
Quantity 68,675
Value £4,943,843
Andrew Wright Financial Controller and Company Secretary
Transaction date
Purchase
Price
98.70
Quantity 25,544
Value £2,874,048
Andrew Wright Financial Controller and Company Secretary
Transaction date
Purchase
Price
125.70
Quantity 57,233
Value £2,907,463
Andrew Wright Financial Controller and Company Secretary
Through Olena Wright, a closely affiliated person
Transaction date
Purchase
Price
0.06
Quantity 344,150
Value £19,892
Andrew Wright Financial Controller and Company Secretary
Transaction date
Purchase
Price
0.06
Quantity 90,554
Value £5,143
Andrew Wright Financial Controller and Company Secretary
Transaction date
Purchase
Price
0.02
Quantity 257,069
Value £5,000
Andrew Wright Financial Controller and Company Secretary
Transaction date
Purchase
Price
0.02
Quantity 840,336
Value £20,000
Adrian Beeston Non-executive Director Executive Director
Transaction date
Purchase
Price
0.02
Quantity 200,000
Value £4,200
Vladislav Sandler Chief Executive Officer and Co-Founder Officer
Transaction date
Purchase
Price
0.02
Quantity 26,800
Value £635
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-30 2022-05-27 B Purchase Andrew Wright

Financial Controller and Company Secretary
68,675
152.05
£4,943,843 		68,675 152.05 £4,943,843
2021-05-19 2021-05-18 B Purchase Andrew Wright

Financial Controller and Company Secretary
25,544
98.70
£2,874,048 		25,544 98.70 £2,874,048
2021-03-09 2021-03-08 B Purchase Andrew Wright

Financial Controller and Company Secretary
57,233
125.70
£2,907,463 		57,233 125.70 £2,907,463
2020-06-30 2020-06-29 B Purchase Andrew Wright

Financial Controller and Company Secretary

Through Olena Wright, a closely affiliated person
344,150
0.06
£19,892 		344,150 0.06 £19,892
2020-06-30 2020-06-29 B Purchase Andrew Wright

Financial Controller and Company Secretary
90,554
0.06
£5,143 		90,554 0.06 £5,143
2020-01-31 2020-01-30 B Purchase Andrew Wright

Financial Controller and Company Secretary
257,069
0.02
£5,000 		257,069 0.02 £5,000
2019-05-01 2019-04-30 B Purchase Andrew Wright

Financial Controller and Company Secretary
840,336
0.02
£20,000 		840,336 0.02 £20,000
2018-02-12 2018-02-09 B Purchase Adrian Beeston

Non-executive Director

Executive Director
200,000
0.02
£4,200 		200,000 0.02 £4,200
2018-02-07 2018-02-05 B Purchase Vladislav Sandler

Chief Executive Officer and Co-Founder

Officer
26,800
0.02
£635 		26,800 0.02 £635
Explore more

More insider trading research around Hemogenyx Pharmaceuticals PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe